TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Francesco Facchinetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.